Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Russia has been experiencing certain trends and developments that are worth exploring.
Customer preferences: Russian customers have been showing an increased interest in vaccines that protect against diseases other than COVID-19. This has led to a rise in demand for other vaccines, such as those for flu, hepatitis, and meningitis. As people are becoming more aware of the importance of vaccination, they are also seeking out more information about the different types of vaccines available and their efficacy.
Trends in the market: The Other Vaccines market in Russia has been growing steadily in recent years, driven by a combination of factors. One of the key drivers has been the increasing prevalence of infectious diseases, which has led to a greater demand for vaccines. In addition, the Russian government has been investing more in healthcare infrastructure, which has made it easier for people to access vaccines. Another trend in the market has been the increasing popularity of combination vaccines, which offer protection against multiple diseases in a single shot.
Local special circumstances: One of the unique features of the Russian market is the high level of government involvement in the healthcare sector. The government plays a significant role in the procurement and distribution of vaccines, and also provides subsidies to help make vaccines more affordable for the general population. In addition, there are a number of local vaccine manufacturers in Russia, which has helped to boost the supply of vaccines and keep prices competitive.
Underlying macroeconomic factors: The Russian economy has been recovering in recent years, following a period of recession. This has led to an increase in disposable income for many Russians, which has in turn led to greater spending on healthcare. In addition, the aging population in Russia has created a greater demand for healthcare services, including vaccines. Finally, the ongoing COVID-19 pandemic has raised awareness of the importance of vaccination, which has helped to drive demand for other types of vaccines as well.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
